Arthur C Louie Selected Research

Neoplasms (Cancer)

1/2019	CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties.
1/2018	Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm.
1/2009	Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arthur C Louie Research Topics

Disease

10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2020 - 03/2011
4	Leukemia 01/2019 - 05/2014
3	Neoplasms (Cancer) 01/2019 - 01/2009
1	Left Ventricular Dysfunction 01/2019
1	Cardiotoxicity 01/2019
1	Cytopenia 05/2014
1	Infections 05/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

9	CPX-351IBA 07/2020 - 03/2011
7	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2020 - 03/2011
6	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 03/2011
3	Liposomes (Liposome)IBA 01/2019 - 01/2009
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2009

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
1	Remission Induction 06/2019
1	Consolidation Chemotherapy 06/2019